These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31440042)

  • 1. Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study.
    Kim KY; Miravitlles M; Sliwinski P; Costello R; Carter V; Tan J; Lapperre TS; Alcazar B; Gouder C; Esquinas C; García-Rivero JL; Kemppinen A; Tee A; Roman-Rodríguez M; Soler-Cataluña JJ; Price D; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1595-1601. PubMed ID: 31440042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.
    Lim JU; Lee JH; Kim JS; Hwang YI; Kim TH; Lim SY; Yoo KH; Jung KS; Kim YK; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2465-2475. PubMed ID: 28860741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Body Mass Index Change on the Prognosis of Chronic Obstructive Pulmonary Disease.
    Kim EK; Singh D; Park JH; Park YB; Kim SI; Park B; Park J; Kim JH; Kim MA; Lee JH; Kim TH; Yoon HK; Oh YM
    Respiration; 2020; 99(11):943-953. PubMed ID: 33264797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in smoking intensity and COPD risk: an observational study in primary care.
    Gilkes A; Hull S; Durbaba S; Schofield P; Ashworth M; Mathur R; White P
    NPJ Prim Care Respir Med; 2017 Sep; 27(1):50. PubMed ID: 28871087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD assessment tests scores are associated with exacerbated chronic obstructive pulmonary disease in Japanese patients.
    Suetomo M; Kawayama T; Kinoshita T; Takenaka S; Matsuoka M; Matsunaga K; Hoshino T
    Respir Investig; 2014 Sep; 52(5):288-95. PubMed ID: 25169844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnicity and risk of hospitalization for asthma and chronic obstructive pulmonary disease.
    Tran HN; Siu S; Iribarren C; Udaltsova N; Klatsky AL
    Ann Epidemiol; 2011 Aug; 21(8):615-22. PubMed ID: 21414801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
    Wedzicha JA; Zhong N; Ichinose M; Humphries M; Fogel R; Thach C; Patalano F; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():339-349. PubMed ID: 28176893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
    Martinez FJ; Lipworth BJ; Rabe KF; Collier DJ; Ferguson GT; Sethi S; Feldman GJ; O'Brien G; Jenkins M; Reisner C
    Respir Res; 2020 May; 21(1):128. PubMed ID: 32450869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survey and analyses of population at high risk of chronic obstructive pulmonary disease in China, 2014].
    Bao HL; Cong S; Wang N; Fan J; Feng YJ; Wang BH; Wang LH; Fang LW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):580-585. PubMed ID: 29860798
    [No Abstract]   [Full Text] [Related]  

  • 11. Body composition parameters and functional status test in predicting future acute exacerbation risk among hospitalized patients with chronic obstructive pulmonary disease.
    Karanikas I; Karayiannis D; Karachaliou A; Papanikolaou A; Chourdakis M; Kakavas S
    Clin Nutr; 2021 Nov; 40(11):5605-5614. PubMed ID: 34656957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology.
    Rhee CK; Chau NQ; Yunus F; Matsunaga K; Perng DW;
    Respirology; 2019 Oct; 24(10):1018-1025. PubMed ID: 31276272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.
    Kania A; Krenke R; Kuziemski K; Czajkowska-Malinowska M; Celejewska-Wójcik N; Kuźnar-Kamińska B; Farnik M; Bokiej J; Miszczuk M; Damps-Konstańska I; Grabicki M; Trzaska-Sobczak M; Sładek K; Batura-Gabryel H; Barczyk A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1613-1621. PubMed ID: 29844667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study.
    Calle Rubio M; Alcázar Navarrete B; Soriano JB; Soler-Cataluña JJ; Rodríguez González-Moro JM; Fuentes Ferrer ME; López-Campos JL
    Int J Chron Obstruct Pulmon Dis; 2017; 12():417-426. PubMed ID: 28182155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition.
    Choi JY; Yoon HK; Shin KC; Park SY; Lee CY; Ra SW; Jung KS; Yoo KH; Lee CH; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():3043-3052. PubMed ID: 31920301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
    Wang C; Sun T; Huang Y; Humphries M; Bai L; Li L; Wang Q; Kho P; Firth R; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():57-68. PubMed ID: 25609940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.